Bastiaan Nuijen

This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Spectrum Pharmaceuticals, Inc., Pharma Mar, S.a., Pharma Mar, S.a., Sociedad Unipersonal. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bastiaan Nuijen. Retrieved from https://idiyas.com/inventor/bastiaan-nuijen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 52(Granted Patents)

Company Filing History:

5 out of 38

Spectrum Pharmaceuticals, Inc.

Pharma Mar, S.a., Sociedad Unipersonal

patents

4. 1 out of 1

Slotervaart Participaties Bv

patent

5. 1 out of 4

Stichting Het Nederlands Kanker Instituut

patents

where one patent can have more than one assignee

Years Active: 2005-2019

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10322183 - Pharmaceutical formulations of ecteinascidin compounds (2019-06-18),

2. 9295666 - Bladder cancer treatment and methods (2016-03-29),

3. 9089544 - Composition (2015-07-28),

4. 8895557 - Pharmaceutical formulations of ecteinascidin compounds (2014-11-25),

5. 8648108 - Medical compositions for intravesical treatment of bladder cancer (2014-02-11),

6. 8563592 - Bladder cancer treatment and methods (2013-10-22),

7. 8420130 - Pharmaceutical formulation of a didemnin compound (2013-04-16),

8. 7977369 - Medical compositions for intravesical treatment of bladder cancer (2011-07-12),

9. 7473681 - Kahalalide F (2009-01-06),

10. 6894071 - Medical compositions for intravesical treatment of bladder cancer (2005-05-17),

Title: The Innovative Contributions of Bastiaan Nuijen in Pharmaceutical Sciences

Introduction

Bastiaan Nuijen, an accomplished inventor based in Amsterdam, Netherlands, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 10 patents, his work has paved the way for advancements in treatments for various proliferative diseases, particularly in oncology.

Latest Patents

Nuijen's recent patents showcase his innovative approach to pharmaceutical formulations. One of his notable works involves ecteinascidin compounds, where he has developed formulations, methods of preparation, and related articles of manufacture for treating proliferative diseases. Additionally, he has also worked on therapeutic compositions for bladder cancer, utilizing an indoloquinone compound that improves solubility and stability through a well-designed formulation vehicle. This innovation enhances the delivery and efficacy of treatments directly to the bladder wall.

Career Highlights

Throughout his career, Bastiaan Nuijen has collaborated with esteemed companies in the pharmaceutical industry, including Spectrum Pharmaceuticals, Inc. and Pharma Mar, S.A. His expertise and dedication have led to significant advancements in drug formulation and delivery systems.

Collaborations

Nuijen's work reflects not only his individual brilliance but also his ability to collaborate effectively with other experts in the field. Notable coworkers Ernie Pfadenhauer and Jos H. Beijnen have contributed to various projects alongside him, further enhancing the impact of their collective research and innovation.

Conclusion

Bastiaan Nuijen's contributions to pharmaceutical innovations position him as a leading figure in his field. His 10 patents and collaborative efforts demonstrate a commitment to advancing medical treatments that address critical health challenges. His ongoing work continues to inspire future innovations in pharmaceutical sciences.

Profile summary based on public USPTO records.